UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 21, 2020

 

 

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-5286   38-0715562
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

2700 West Front Street

Statesville, North Carolina

  28677
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 704-873-7202

N/A

(Former name or former address, if changed since last report.)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $2.50 par value   KEQU   NASDAQ Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 8.01

Other Events

On July 21, 2020, Kewaunee Scientific Corporation issued a press release announcing that it had received the necessary approvals to establish a Technical Service Organization within the Kingdom of Saudi Arabia. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits:

 

Exhibit No.

    
99.1    Press Release of Kewaunee Scientific Corporation dated July 21, 2020.


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

                    (Registrant)
    Kewaunee Scientific Corporation
Date: July 21, 2020       /s/ Donald T. Gardner III
      Donald T. Gardner III
     

Vice President, Finance and

Chief Financial Officer

EX-99.1

Exhibit 99.1

 

LOGO

Kewaunee Scientific Corporation Accelerates Growth in The Middle East & Africa Market

by establishing a Local Entity in Saudi Arabia

 

Exchange:   NASDAQ (KEQU)         Contact:  

Thomas D. Hull III

704-871-3290

Statesville, N.C. – July 21, 2020 – Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products since 1906, today announced it has received the necessary approvals to establish a Technical Service Organization within the Kingdom of Saudi Arabia. Kewaunee Scientific Saudia Co., established in Riyadh, will support Kewaunee’s continued focus on growing in the Middle East region and will enable Kewaunee access to the area’s diverse talent pool to support these efforts. This team will also support Kewaunee’s activity in North and Sub-Saharan Africa.

“We expect the Middle East and Africa to be growth markets for Kewaunee over the long term as investments continue to be made in these regions to modernize their respective economies. We have invested in building relationships with key customers in the Middle East over the past decade and have delivered some of the largest and most complex laboratory projects in the region,” said Thomas D. Hull III, President and Chief Executive Officer of Kewaunee Scientific Corporation.

“Having delivered many prestigious projects in the Middle East, our next logical step was to be closer to our customers so we can better serve them, bringing them Kewaunee’s full range of products and services. Thanks to our enhanced presence in Saudi Arabia, we expect to be more successful in building lasting, recurring relationships with our customers in the region. This regional presence will also help our team offer more tailored solutions for the market,” said B. Sathyamurthy, Vice President, International Operations, Kewaunee Scientific Corporation, Singapore and Managing Director - International Operations.

About Kewaunee Scientific Corporation

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company’s products include steel, wood, and laminate casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

The Company’s corporate headquarters are in Statesville, North Carolina, USA. Direct sales offices are in the United States, India and Singapore. Three manufacturing facilities are in Statesville serving the domestic and international markets, and one manufacturing facility is in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India.

Kewaunee Scientific’s website is at www.kewaunee.com. Kewaunee International Group website is at www.kewaunee.in.

 

P. O. BOX 1842, STATESVILLE, NORTH CAROLINA 28687-1842        2700 WEST FRONT STREET, STATESVILLE, NORTH CAROLINA 28677-2927

PHONE 704-873-7202        FAX 704-873-1275